Open the mobile version, with barcode scanning
Class II Ongoing

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.

Why: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.

Company
Pfizer
Manhattan, NY, United States
Reported
Oct 28, 2026
Recall started
Sep 29, 2026
Where sold
US Nationwide and Puerto Rico
Amount
15,815 100-count bottles
Full product description
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
Lots / codes affected
Lot # 24W06, Exp: 11/30/2026

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.